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Abstract. Modern modalities of radiation treatment therapy allow irradiation of the tumor to high dose values and 
irradiation of organs at risk (OARs) to low dose values at the same time. In this paper we study optimal radiation 
treatment plans made in Monaco system. The first aim of this study was to evaluate dosimetric features of Monaco 
treatment planning system using biological versus dose-based cost functions for the OARs and irradiation targets (namely 
tumors) when the full potential of built-in biological cost functions is utilized. The second aim was to develop criteria for 
the evaluation of radiation dosimetry plans for patients based on the macroscopic radiobiological criteria - TCP/NTCP. In 
the framework of the study four dosimetric plans were created utilizing the full extent of biological and physical cost 
functions using dose calculation-based treatment planning for IMRT Step-and-Shoot delivery of stereotactic body 
radiation therapy (SBRT) in prostate case (5 fractions  per 7 Gy). 
INTRODUCTION 
The goal of radiation therapy is to maximize tumor response and minimize side effects in normal tissues. 
However, the optimization of treatment plans has traditionally been performed using surrogate approaches, such as 
the maximization of tumor dose and minimization of dose to organs at risk OARs. Currently, the biological effects 
of expected treatment efficiency are estimated mainly by the absorbed dose in the tumor and surrounding tissues, 
taking into account the total treatment time and fractionation. These principles have a statistical nature and are not 
based on clear biological principles. The progress in radiobiology led to the development of new models for 
assessing the cell death and complications in normal tissues, taking into account their biological characteristics. The 
currently used method for assessing dosimetric radiation plans for patients based on dose-volume limitations has a 
significant drawback: equally evaluate dosimetric plans while they meet the same dose-volume limitations. 
Therefore, there is a growing interest in the possibility of using biological target functions combining tissue 
architecture and dose sensitivity (an equivalent uniform dose concept, EUD), when evaluating irradiation plans as an 
alternative to dose-volume limitations [1]. An equivalent uniform dose concept has acquired significant popularity in 
the area of biologically based treatment planning as it involves the information about the organ functional 
architecture which is serial or parallel. It is in “dose-volume” region and is more familiar for clinicians. It also 
possesses desired mathematical properties. However, this function does not rely on too much necessary parameters 
to determine the effectiveness of radiotherapy, such as the case with tumor control probability (TCP) and normal 
tissue complication probability (NTCP). It was realized long ago that incorporating biological response functions, 
such as a TCP and NTCP, into the treatment planning process has the potential to produce more optimal plans 
resulting in improved treatment outcomes. Biological optimization became an even more attractive concept with the 
advent of the intensity-modulated radiation therapy IMRT and inverse treatment planning [2]. 
Physics of Cancer: Interdisciplinary Problems and Clinical Applications
AIP Conf. Proc. 1882, 020074-1–020074-4; doi: 10.1063/1.5001653
Published by AIP Publishing. 978-0-7354-1562-1/$30.00
020074-1
The first aim of this study was to evaluate dosimetric features of Monaco treatment planning system using 
biological versus dose-based cost functions for the OARs and irradiation targets (namely tumors) when the full 
potential of built-in biological cost functions is utilized. The second aim was to evaluate the dosimetric plans for 
patients based on the macroscopic radiobiological criteria—TCP/NTCP. 
METHODS AND MATERIALS 
All radiation treatment plans have been simulated using Elekta Monaco planning system (v. 5.10) and have been 
delivered with an Elekta Synergy linear accelerator (40u40 cm maximum field size with 0.5 cm width of leaves) 
using kV cone-beam CT capability which was performed at Tomsk Regional Oncology Center (Tomsk, Russia). In 
the framework of this study four plans have been created utilizing the full extent of biological and physical cost 
functions [1, 2] using dose calculation-based treatment planning for IMRT Step-and-Shoot delivery of stereotactic 
body radiation therapy (SBRT) in prostate case (7 Gy for 5 fractions). 
The biological plans named IMRTBio (hard condition for Target) and IMRTBio2 (priority for OAR) performed 
the following cost functions: Target EUD, Serial and Parallel. To create IMRTPh1 (priority for OAR) and IMRTPh2 
(hard condition for Target) physical plans such functions as Target Penalty, Quadratic Overdose, Maximum Dose 
and Overdose DVH were used. 
The evaluation of treatments plans was performed based on conformity index CI and heterogeneity index HI [3, 
4]. The quality of the plan delivery by accelerator was assessed by measuring the transverse dose distribution using 
IBA plate ion chamber-array phantom, MatriXX (IBA Dosimetry GmbH, Germany). The passing rates were 
determined according to the percent difference and distance-to-agreement (DTA) 3%–3 mm criterion [4]. 
The selection of the most effective radiotherapy plans was made by evaluating the UTCP (Uncomplicated Tumor 
Control Probability) criterion, the value of which is interpreted as the probability of controlling a tumor without 
radiation complications: 
 UTCP = TCP (1 – NTCP), (1) 
where TCP—tumor control probability value, NTCP—normal tissue complication probability value. 
For this purpose, automated import of cumulative dose-to-volume histograms—cDVH from the Monaco 
planning system was realized and then they were transformed into differential distributions—dDVH, necessary for 
the calculation of TCP/NTCP. 
To calculate TCP and NTCP values in this paper Niemierko model [5–7] was used. In Niemierko model TCP 
value could be calculated as follows: 
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where 50TCD 65 Gy, 50 2.5,J   10a    for prostate cancer according to [8], 
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Here 1.5 0.5D E  r  is a radiobiological constant for prostate cancer according to [8], iv  is the part of PTV that 
obtains the irradiation dose i ,D fn  is the number of fractions.  
NTCP value could be calculated as follows [5–7]: 
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where 50TD 80 Gy, 50 2.7,J   8a   for rectum and 50TD 80 Gy, 50 3.6,J   7a   for bladder [8]. EUD in 
Eq. (4) is calculated using Eq. (3), but D E  ratio is taken for OARs. We used values D E= 3 both for rectum and 
bladder [8]. 
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FIGURE 1. The comparison of biological-based and physical plans for prostate patient 
 
RESULTS 
The delivery parameters such as the number of segments (S) and number of MU (MU) for SBRT prostate plans 
were as follows: for IMRTBio plans S = 66 and MU = 1406, for IMRTBio2 plan S = 75 and MU = 1304, for 
IMRTPh plans S = 77 and MU = 1896. 
The comparison of biology-based (IMRTBio, IMRTBio2) and physical (IMRTPh1, IMRTPh2) SBRT prostate 
plans on based dose-volume histogram for GTV, PTV, bladder, rectum, femoral heads (L,R) is presented in Fig. 1. 
To evaluate tolerance doses on OAR for SBRT with fivefold fraction in all plans TG-101 protocols were used, i.e. 
for bladder Dose of 18.3 Gy no more 15cc of Volume and MaxDose < 38 Gy, for rectum Dose of 25 Gy no more 
20cc of Volume and MaxDose < 38 Gy, femoral heads Dose of 30 Gy no more 10cc of Volume. 
The evaluation parameters of Monaco plans quality with respect to target coverage, conformity and 
heterogeneity indices, and passing rates are listed in Table 1. 
In Table 2 TCP and NTCP values calculated for all treatment plans are presented. 
 
TABLE 1. The evaluation parameters of IMRT SBRT Monaco plans quality 
Plans Structure % of volume 
% of 
dose Max dose CI HI Passing 
IMRTBio GTV PTV 
100 
98 
100 
98 
38.6 
39 
0.86 
0.77 
1.02 
1.06 99.6% 
IMRTBio2 GTV PTV  
100 
95 
99 
94 
37.5 
37.5 
0.7 
0.62 
1.03 
1.08 98.1% 
IMRTPh1 GTV PTV 
100 
95 
99 
95 
38.6 
37.8 
0.69 
0.7 
1.04 
1.07 96.5% 
IMRTPh2 GTV PTV 
100 
98 
99 
97 
38.2 
38.5 
0.6 
0.6 
1.09 
1.10 96.2% 
 
TABLE 2. TCP and NTCP values calculated for all treatment plans 
Plans TCP NTCP rectum NTCP bladder 
IMRTBio 99% 1.1% 0 
IMRTBio2 96%  0.6% 0 
IMRTPh1 97% 0.7% 0 
IMRTPh2 97% 0.6% 0 
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FIGURE 2. Differential dose-volume distributions for PTV of the patient irradiation plans under consideration 
 
The calculation using Eqs. (2)–(4) is carried out by differential dose-volume distributions {vi, Di} for PTV and 
OARs, obtained from the data shown in Fig. 1. Figure 2 shows the differential dose-volume distributions for PTV 
calculated for the patient dosimetric plans discussed above. 
DISCUSSION 
Thus, the best result for control of target irradiation shows plan IMRTBio, but the probabilities of critical organ 
exposures have shown good results both in terms of physical and biological functions. Nevertheless biological cost 
functions offer more control over the dose distribution than physical functions, and a smaller number of them is 
required to fully shape the dose distribution. 
CONCLUSION 
Modern radiotherapy can delivery highly conformal dose distribution and can create different dose level within 
the treated volume. 
The evaluation of dosimetric plans obtained using macroscopic radiobiological criteria showed that SBRT plans 
optimized using biological-motivated cost-functions result in highly conformal dose distributions. The plans offer 
shorter treatment-time benefits and provide efficient dose delivery without compromising the plan conformity for 
tumors in the prostate, thereby improving patient comfort and clinical throughput. The short delivery times minimize 
the risk of patient setup and intrafraction motion errors often associated with long SBRT treatment delivery times. 
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